Cardioembolic Ischemic Stroke Gene Expression Fingerprint in Blood: a Systematic Review and Verification Analysis

[1]  D. Dobrev,et al.  Role of inflammatory signaling in atrial fibrillation. , 2019, International journal of cardiology.

[2]  Man Wang,et al.  Crosstalk between MicroRNAs and Peroxisome Proliferator-Activated Receptors and Their Emerging Regulatory Roles in Cardiovascular Pathophysiology , 2018, PPAR research.

[3]  M. Elkind.  Atrial Cardiopathy and Stroke Prevention , 2018, Current Cardiology Reports.

[4]  S. Connolly,et al.  Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source , 2018, The New England journal of medicine.

[5]  Alejandro Bustamante,et al.  Yield of atrial fibrillation detection with Textile Wearable Holter from the acute phase of stroke: Pilot study of Crypto-AF registry. , 2018, International journal of cardiology.

[6]  S. Nattel,et al.  Atrial Cardiomyopathy: A Useful Notion in Cardiac Disease Management or a Passing Fad? , 2017, Journal of the American College of Cardiology.

[7]  A. Goette,et al.  CREM-transgene mice: An animal model of atrial fibrillation and thrombogenesis. , 2017, Thrombosis research.

[8]  H. Kamel,et al.  Atrial cardiopathy: a mechanism of cryptogenic stroke , 2017, Expert review of cardiovascular therapy.

[9]  G. Jickling,et al.  RNA as a stroke biomarker , 2017 .

[10]  J. Montaner,et al.  Blood markers of inflammation and endothelial dysfunction in cardioembolic stroke: systematic review and meta-analysis , 2017, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[11]  A. Orekhov,et al.  PPAR in Cardiovascular Disorders , 2016, PPAR research.

[12]  H. Canpınar,et al.  Monocyte Toll-Like Receptor Expression in Patients With Atrial Fibrillation. , 2016, The American journal of cardiology.

[13]  Gregory Y H Lip,et al.  Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications. , 2015, Journal of the American College of Cardiology.

[14]  Julian Sonderer,et al.  Aetiological blood biomarkers of ischaemic stroke. , 2015, Swiss medical weekly.

[15]  Natalia S. Rost,et al.  B-Type Natriuretic Peptides Help in Cardioembolic Stroke Diagnosis: Pooled Data Meta-Analysis , 2015, Stroke.

[16]  Yenn-Jiang Lin,et al.  Antiplatelet therapy: Vorapaxar in diabetes and MI , 2015, Nature Reviews Cardiology.

[17]  Yun Gao,et al.  Pellino1-mediated TGF-β1 synthesis contributes to mechanical stress induced cardiac fibroblast activation. , 2015, Journal of molecular and cellular cardiology.

[18]  Joseph P. Broderick,et al.  Gene Expression in Peripheral Immune Cells following Cardioembolic Stroke Is Sexually Dimorphic , 2014, PloS one.

[19]  M. Stenzel-Poore,et al.  Toll-like receptors and ischemic brain injury. , 2014, Journal of neuropathology and experimental neurology.

[20]  G. Hankey.  Secondary stroke prevention , 2014, The Lancet Neurology.

[21]  J. Kusak,et al.  Multilocus Detection of Wolf x Dog Hybridization in Italy, and Guidelines for Marker Selection , 2014, PloS one.

[22]  R. Sacco,et al.  Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study , 2014, PloS one.

[23]  N. Rao,et al.  Analysis on Differential Gene Expression Data for Prediction of New Biological Features in Permanent Atrial Fibrillation , 2013, PloS one.

[24]  B. Bogerts,et al.  Wide distribution of CREM immunoreactivity in adult and fetal human brain, with an increased expression in dentate gyrus neurons of Alzheimer’s as compared to normal aging brains , 2013, Amino Acids.

[25]  Shih‐Ann Chen,et al.  Extracellular matrix of collagen modulates arrhythmogenic activity of pulmonary veins through p38 MAPK activation. , 2013, Journal of molecular and cellular cardiology.

[26]  T. Rauen,et al.  cAMP responsive element modulator: a critical regulator of cytokine production. , 2013, Trends in molecular medicine.

[27]  G. Lip,et al.  Inflammation in atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[28]  A. Tuttolomondo,et al.  Inflammation in ischemic stroke subtypes. , 2012, Current pharmaceutical design.

[29]  W. Freeman,et al.  Prevention of Cardioembolic Stroke , 2011, Neurotherapeutics.

[30]  F. Sharp,et al.  Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  J. Broderick,et al.  Signatures of cardioembolic and large‐vessel ischemic stroke , 2010, Annals of neurology.

[32]  N. Sawada,et al.  Novel aspects of the roles of Rac1 GTPase in the cardiovascular system. , 2010, Current opinion in pharmacology.

[33]  Gregory Y H Lip,et al.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.

[34]  J. Bogousslavsky,et al.  Classification of Stroke Subtypes , 2009, Cerebrovascular Diseases.

[35]  S. Corrao,et al.  Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke , 2009, Thrombosis and Haemostasis.

[36]  U. Dirnagl,et al.  Preventive Antibacterial Therapy in Acute Ischemic Stroke: A Randomized Controlled Trial , 2008, PloS one.

[37]  J. Gregg,et al.  Gene Expression in Peripheral Blood Differs after Cardioembolic Compared with Large-Vessel Atherosclerotic Stroke: Biomarkers for the Etiology of Ischemic Stroke , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  M. Aguilar,et al.  Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.

[39]  S. Janssens,et al.  Pellino Proteins: Novel Players in TLR and IL-1R Signalling , 2007, Journal of cellular and molecular medicine.

[40]  R. Dantzer,et al.  C-jun N-terminal kinase mediates tumor necrosis factor-alpha suppression of differentiation in myoblasts. , 2006, Endocrinology.

[41]  P. Kirchhof,et al.  Heart-directed Expression of a Human Cardiac Isoform of cAMP-Response Element Modulator in Transgenic Mice* , 2005, Journal of Biological Chemistry.

[42]  T. C. Liu,et al.  Cloning and expression of ZAK, a mixed lineage kinase-like protein containing a leucine-zipper and a sterile-alpha motif. , 2000, Biochemical and biophysical research communications.

[43]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[44]  J. Marler,et al.  Measurements of acute cerebral infarction: a clinical examination scale. , 1989, Stroke.

[45]  H. Schouten,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.

[46]  J. Healey,et al.  Cardioembolic Stroke. , 2017, Circulation research.

[47]  Stroke: Highlights of Selected Articles. , 2017, Stroke.

[48]  Cumara B. O’Carroll,et al.  Cardioembolic Stroke , 2017, Continuum.

[49]  V. Chair,et al.  Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.

[50]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.